Effect of sustained heparin release from PCL/chitosan hybrid small-diameter vascular grafts on anti-thrombogenic property and endothelialization.

Thrombus formation and subsequent occlusion are the main reasons for the failure of small-diameter vascular grafts. In this study, a hybrid small-diameter vascular graft was developed from synthetic polymer poly(ε-caprolactone) (PCL) and natural polymer chitosan (CS) by the co-electrospinning technique. Heparin was immobilized on the grafts through ionic bonding between heparin and CS fibers. The immobilization was relatively stable, and heparin could continuously release from the grafts for more than 1month. Heparin functionalization evidently improved the hemocompatibility of the PCL/CS vascular grafts, which was illustrated by the reduced platelet adhesion and prolonged coagulation time (activated partial thromboplastin time, prothrombin time and thromboplastin time) as shown in the human plasma assay, and was further confirmed by the ex vivo arteriovenous shunt experiment. In vitro cell proliferation assay showed that heparin can promote the growth of human umbilical vein endothelial cells, while moderately inhibiting the proliferation of vascular smooth muscle cells, a main factor for neointimal hyperplasia. Implantation in rat abdominal aorta was performed for 1month. Results indicate that sustained release of heparin provided optimal anti-thrombogenic effect by reducing thrombus formation and maintaining the patency. Furthermore, heparin functionalization also enhanced in situ endothelialization, thereby preventing the occurrence of restenosis. In conclusion, it provides a facile and useful technique for the development of heparinized medical devices, including vascular grafts.

[1]  M. Kipper,et al.  Polysaccharide-based polyelectrolyte multilayer surface coatings can enhance mesenchymal stem cell response to adsorbed growth factors. , 2010, Biomacromolecules.

[2]  W. Gerthoffer.  Mechanisms of vascular smooth muscle cell migration. , 2007, Circulation research.

[3]  J. Beamish,et al.  The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype. , 2009, Biomaterials.

[4]  Hongjun Wang,et al.  The involvement of integrin β1 signaling in the migration and myofibroblastic differentiation of skin fibroblasts on anisotropic collagen-containing nanofibers. , 2012, Biomaterials.

[5]  Geunhyung Kim,et al.  Fabrication of electrospun polycaprolactone biocomposites reinforced with chitosan for the proliferation of mesenchymal stem cells , 2011 .

[6]  M. Kipper,et al.  Polyelectrolyte multilayer assembly as a function of pH and ionic strength using the polysaccharides chitosan and heparin. , 2008, Biomacromolecules.

[7]  T. Crouzier,et al.  Ion pairing and hydration in polyelectrolyte multilayer films containing polysaccharides. , 2009, Biomacromolecules.

[8]  D. Vorp,et al.  Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. , 2008, Biomaterials.

[9]  B. Caleb,et al.  Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.

[10]  J. Feijen,et al.  Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. , 2001, Biomaterials.

[11]  David G Simpson,et al.  A three-layered electrospun matrix to mimic native arterial architecture using polycaprolactone, elastin, and collagen: a preliminary study. , 2010, Acta biomaterialia.

[12]  Christopher J. Jones,et al.  Characterization of heparin impurities with HPLC-NMR using weak anion exchange chromatography. , 2009, Analytical chemistry.

[13]  C. Pillai,et al.  Chitin and chitosan polymers: Chemistry, solubility and fiber formation , 2009 .

[14]  Jia-cong Shen,et al.  Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. , 2005, Biomaterials.

[15]  J. Mano,et al.  New poly(epsilon-caprolactone)/chitosan blend fibers for tissue engineering applications. , 2010, Acta biomaterialia.

[16]  Jun Zhang,et al.  Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. , 2012, Biomaterials.

[17]  A. Seifalian,et al.  Addressing thrombogenicity in vascular graft construction. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[18]  David A. Vorp,et al.  A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend. , 2009, Biomaterials.

[19]  David L Kaplan,et al.  Gel spinning of silk tubes for tissue engineering. , 2008, Biomaterials.

[20]  Li Shen,et al.  The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. , 2009, Biomaterials.

[21]  M. Chan-Park,et al.  Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. , 2009, Journal of biomedical materials research. Part A.

[22]  N. L'Heureux,et al.  Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.

[23]  M. Guler,et al.  Growth factor binding on heparin mimetic peptide nanofibers. , 2012, Biomacromolecules.

[24]  Benjamin Chu,et al.  Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts , 2007, Proceedings of the National Academy of Sciences.

[25]  G. Bowlin,et al.  Angiogenic potential of human macrophages on electrospun bioresorbable vascular grafts , 2009, Biomedical materials.

[26]  Miqin Zhang,et al.  Fabrication and cellular compatibility of aligned chitosan–PCL fibers for nerve tissue regeneration , 2011 .

[27]  S. Raghavan,et al.  Chitosan-based scaffolds for the support of smooth muscle constructs in intestinal tissue engineering. , 2012, Biomaterials.

[28]  Yubo Fan,et al.  Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF. , 2013, Biomaterials.

[29]  A. Mikos,et al.  Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. , 2006, Biomacromolecules.

[30]  S. Madihally,et al.  Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations. , 2000, Biomaterials.

[31]  A. Tekinay,et al.  Heparin mimetic peptide nanofibers promote angiogenesis. , 2011, Biomacromolecules.

[32]  Robert J. Linhardt,et al.  Heparin—Protein Interactions , 2002 .

[33]  Miqin Zhang,et al.  Aligned chitosan-based nanofibers for enhanced myogenesis , 2010 .

[34]  Song Li,et al.  The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds. , 2010, Biomaterials.

[35]  Robert Gurny,et al.  Degradation and Healing Characteristics of Small-Diameter Poly(&egr;-Caprolactone) Vascular Grafts in the Rat Systemic Arterial Circulation , 2008, Circulation.

[36]  S. Ramakrishna,et al.  Chitosan nanofibers from an easily electrospinnable UHMWPEO-doped chitosan solution system. , 2008, Biomacromolecules.

[37]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling , 2010, Proceedings of the National Academy of Sciences.

[38]  Sangwon Chung,et al.  Bioresorbable elastomeric vascular tissue engineering scaffolds via melt spinning and electrospinning. , 2010, Acta biomaterialia.